2025 年全球植入市场报告

预计未来几年植入的市场规模将快速成长。到 2029 年，这一数字将成长至 2,103.6 亿美元，复合年增长率为 11.1%。预测期内的成长可归因于客製化和个人化、微创手术的成长、向再生医学的转变、远端监控和远端医疗以及支持性法规环境。预测期内的主要趋势包括客製化和个人化植入、生物分解性和生物可吸收植入物、生物材料、再生医学和组织工程的进步、智慧植入和穿戴式技术。

预计未来几年慢性病发病率的上升将推动植入市场的成长。慢性疾病，包括心血管疾病和关节炎，定义为持续一年以上、需要持续医疗照护且限制日常活动的医疗问题。植入可以在此类慢性疾病的管理和监测中发挥关键作用，并有助于降低此类疾病相关的死亡率。例如，2024年7月，澳洲健康与福利研究所报告称，慢性阻塞性肺病（COPD）将成为2022年澳洲7691人死亡的主要原因，相当于每10万人中有29.6人死亡，占所有死亡人数的4.0%。因此，慢性病发病率的不断上升正在推动植入市场的成长。

随着老龄化社会的到来（老年人口比例不断增加），植入市场正在经历成长。植入有多种用途，包括即时健康监测、药物传递和组织再生，以解决与老龄化相关的健康问题。根据世界卫生组织2022年10月发布的预测，到2030年，全球每六人就有一人年龄超过60岁，人口结构正在发生重大变化。 60 岁及以上人口的人口结构发生变化，从 2020 年的 10 亿增加到 14 亿，这清楚地表明对植入的需求增加。到 2050 年，全球 60 岁及以上人口预计将增加一倍，达到 21 亿。因此，老化正在成为植入市场扩张的关键因素。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第 4 章市场：宏观经济情景，包括利率、通膨、地缘政治、新冠疫情以及復苏对市场的影响

第五章 全球成长分析与策略分析框架

• 全球植入PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素、限制因素）
• 最终用途产业分析
• 全球植入市场：成长率分析
• 全球植入市场表现：规模与成长，2019 年至 2024 年
• 全球植入市场预测：2024-2029 年及 2034 年规模与成长
• 全球植入总目标市场 (TAM)

第六章 市场细分

• 全球植入市场：按类型、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 心血管植入
• 人工植牙
• 脊椎植入
• 整形外科植入
• 眼科植入
• 其他类型
• 全球植入市场（按材料、性能和预测）2019-2024 年、2024-2029 年、2034 年
• 金属
• 陶瓷製品
• 聚合物
• 生物
• 全球植入市场按来源、性能和预测，2019-2024 年、2024-2029 年、2034 年
• 同种异体移植
• 自体移植
• 异种移植
• 合成
• 全球植入市场：按最终用户、绩效和预测，2019-2024 年、2024-2029 年、2034 年
• 门诊手术中心
• 诊所
• 医院
• 其他最终用户
• 全球植入市场：心血管植入细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 支架
• 心臟瓣膜
• 心律调节器
• 全球植入市场：人工植牙细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 骨内植入
• 骨膜下植入
• 颧骨植入
• 全球植入市场：脊椎植入细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 脊椎固定器
• 椎间盘
• 脊柱棒和脊柱板
• 全球植入市场：整形外科植入细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 关节重建植入
• 骨折固定装置
• 骨板和螺丝
• 全球植入市场：眼科植入细分市场、类型、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 人工水晶体（IOL）
• 视网膜植入
• 角膜植入
• 全球植入市场：按类型、性能和预测细分，2019-2024 年、2024-2029 年、2034 年
• 人工电子耳
• 组织工程植入
• 生医材料支架

第七章 区域和国家分析

• 全球植入市场：按地区、绩效及预测，2019-2024 年、2024-2029 年、2034 年
• 全球植入市场：依国家、表现及预测，2019-2024 年、2024-2029 年、2034 年

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章 澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第 17 章 德国市场

第 18 章 法国市场

第 19 章：义大利市场

第 20 章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第 25 章：加拿大市场

第26章 南美洲市场

第 27 章：巴西市场

第28章 中东市场

第 29 章：非洲市场

第 30 章竞争格局与公司概况

• 植入市场：竞争格局
• 植入市场：公司简介
  • Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Dentsply Sirona Inc. Overview, Products and Services, Strategy and Financial Analysis
  • Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

第31章 其他大型创新企业

• Arthrex Inc.
• Boston Scientific Corporation
• Smith & Nephew PLC
• B. Braun Melsungen AG
• Victrex PLC
• Straumann Holding AG
• Danaher Corporation
• Cardinal Health Inc.
• Organogenesis Holdings Inc.
• Exactech Inc.
• Osprey Medical Inc.
• Edwards Lifesciences Corporation
• Biotronik SE & Co. KG
• aap Implantate AG
• Abbott Laboratories

第 32 章 全球市场竞争基准化分析与仪表板

第33章 重大併购

第 34 章 近期市场趋势

第 35 章 高市场潜力国家、细分市场与策略

• 2029 年植入市场：提供新机会的国家
• 2029 年植入市场：细分市场将带来新机会
• 2029 年植入市场：成长策略
  • 基于市场趋势的策略
  • 竞争对手的策略

第 36 章 附录

Bio-implants are sophisticated medical devices or prostheses crafted from materials sourced from human or animal origin, as well as biosynthetic materials. These implants serve the crucial function of replacing missing tissues and supporting damaged biological structures, ultimately enhancing the body's biological functions. Bio-implants are instrumental in assisting and regulating various human physiological functions.

Within the bio-implant category, there are several main types, including cardiovascular implants, dental implants, spinal bio-implants, orthopedic implants, ophthalmic implants, and others. Cardiovascular implants, such as heart valves and coronary stents, play a vital role in treating cardiac complications, designed to remain within a patient's body to support healthy blood arteries and a functioning heart. Bio-implants are crafted from diverse materials, including metallic, ceramic, polymer, and biological components. They originate from different sources such as allograft, autograft, xenograft, and synthetic materials. These bio-implants find application in various healthcare settings, including ambulatory surgical centers, clinics, hospitals, and other end-user facilities.

The bio-implants market research report is one of a series of new reports from The Business Research Company that provides bio-implants market statistics, including bio-implants industry global market size, regional shares, competitors with a bio-implants market share, detailed bio-implants market segments, market trends and opportunities, and any further data you may need to thrive in the bio-implants industry. This bio-implants market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The bio-implants market size has grown strongly in recent years. It will grow from $125.48 billion in 2024 to $137.99 billion in 2025 at a compound annual growth rate (CAGR) of 10.0%. The growth in the historic period can be attributed to aging population and chronic diseases, rise in surgical procedures, increased life expectancy, regulatory support and standards.

The bio-implants market size is expected to see rapid growth in the next few years. It will grow to $210.36 billion in 2029 at a compound annual growth rate (CAGR) of 11.1%. The growth in the forecast period can be attributed to customization and personalization, growth in minimally invasive procedures, shift towards regenerative medicine, remote monitoring and telemedicine, supportive regulatory environment. Major trends in the forecast period include customized and personalized implants, biodegradable and bioresorbable implants, advancements in biomaterials, regenerative medicine and tissue engineering, smart implants and wearable technologies.

The rising prevalence of chronic conditions is anticipated to drive growth in the bio-implant market in the coming years. Chronic conditions, including cardiovascular diseases and arthritis, are defined as medical issues that persist for a year or longer, necessitate ongoing medical care, and limit daily activities. Bio-implants play a crucial role in managing and monitoring these chronic conditions, contributing to a reduction in mortality rates associated with such diseases. For instance, in July 2024, the Australian Institute of Health and Welfare reported that chronic obstructive pulmonary disease (COPD) was responsible for 7,691 deaths in Australia in 2022, equating to 29.6 deaths per 100,000 people and accounting for 4.0% of all fatalities. Therefore, the increasing prevalence of chronic conditions is propelling the growth of the bio-implant market.

The bio-implants market is experiencing growth attributed to the aging population, characterized by an increasing proportion of elderly individuals in societies. Bio implants serve diverse purposes, including real-time health monitoring, drug delivery, and tissue regeneration, catering to age-related health issues. The World Health Organization's October 2022 projections indicate a significant demographic shift, with one in six individuals globally expected to be 60 years or older by 2030. This demographic transition, marked by a rise from 1 billion in 2020 to 1.4 billion individuals aged 60 and over, is a clear indication of the increasing demand for bio-implants. Looking ahead to 2050, the global population of individuals aged 60 and older is projected to double to 2.1 billion. The aging population is thus a significant driver for the expanding bio-implants market.

In the bio-implant market, key trends are centered around technological advancements, with major players focusing on innovative biomaterial technology, particularly 3D printing for bio-implant systems. This additive manufacturing technique produces 3D structures using cells and biomaterials, deviating from traditional metals and polymers. A notable example is the March 2022 launch of Evonik Industries AG's osteoconductive VESTAKEEP iC4800 3DF PEEK filament. This high-performance polymer, based on 3D-printing technology, enhances osteointegration between bone and implant, expediting bone healing. Notable features include impressive biocompatibility, biostability, and enhanced osteoconductive qualities, reflecting the forefront of technical innovation in the bio-implant sector.

Major companies in the bio-implants market are actively introducing novel implant solutions to elevate patient care standards. Notably, the introduction of the REGENETEN Bioinductive Implant by Smith+Nephew in July 2023 stands out. This collagen-based implant supports the body's natural healing response, fostering the growth of new tendon-like tissue to reinforce existing tendons. Launched in India after completing over 100,000 global procedures, this arthroscopically delivered implant has demonstrated promising results in rotator cuff disease. Clinical trials have shown an 86% relative reduction in re-tear rates at 12 months compared to conventional surgery alone, positioning the REGENETEN Bioinductive Implant as a transformative advancement in bio-implant technology.

In August 2022, CONMED Corporation, a prominent US-based medical technology company, made a strategic move by acquiring Biorez Inc., a medical device start-up, for an undisclosed amount. This acquisition is poised to enhance CONMED's sports medicine portfolio, with the addition of Biorez bringing innovative capabilities to the forefront. The acquisition strategically positions CONMED to capitalize on emerging technologies and reinforces its commitment to growth and innovation in the competitive bio-implant market.

Major companies operating in the bio-implants market are Medtronic PLC, Stryker Corporation, Zimmer Biomet Holdings Inc., Dentsply Sirona Inc., Johnson & Johnson, Arthrex Inc., Boston Scientific Corporation, Smith & Nephew PLC, B. Braun Melsungen AG, Victrex PLC, Straumann Holding AG, Danaher Corporation, Cardinal Health Inc., Organogenesis Holdings Inc., Exactech Inc., Osprey Medical Inc., Edwards Lifesciences Corporation, Biotronik SE & Co. KG, aap Implantate AG, Abbott Laboratories, Biotronik Inc., Cook Medical LLC, Globus Medical Inc., Integra LifeSciences Holdings Corporation, LivaNova PLC, MicroPort Scientific Corporation, NuVasive Inc., Orthofix Medical Inc., RTI Surgical Holdings Inc., Terumo Corporation

North America was the largest region in the bio-implants market share in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bio-implants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the bio-implants market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The bio implants market consists of sales stents, pacing devices, orthobiologics, trauma implants, sport medicines, thoracolumber implants, intervertebral spacers, machined allograft spacers, and motion preservation implants. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Bio-Implants Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on bio-implants market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
• Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on the latest market shares.
• Benchmark performance against key competitors.
• Suitable for supporting your internal and external presentations with reliable high quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for bio-implants ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The bio-implants market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.

• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

• Markets Covered:1) By Type: Cardiovascular Implants; Dental Implants; Spinal Bio-Implants; Orthopedic Implants; Ophthalmic Implants; Other Types
• 2) By Material: Metallic; Ceramic; Polymer; Biological
• 3) By Origin: Allograft; Autograft; Xenograft; Synthetic
• 4) By End-User: Ambulatory Surgical Centers; Clinics; Hospital; Other End-Users
• Subsegments:
• 1) By Cardiovascular Implants: Stents; Heart Valves; Pacemakers
• 2) By Dental Implants: Endosteal Implants; Subperiosteal Implants; Zygomatic Implants
• 3) By Spinal Bio-Implants: Spinal Fusion Devices; Intervertebral Discs; Spinal Rods And Plates
• 4) By Orthopedic Implants: Joint Replacement Implants; Fracture Fixation Devices; Bone Plates And Screws
• 5) By Ophthalmic Implants: Intraocular Lenses (IOLs); Retinal Implants; Corneal Implants
• 6) By Other Types: Cochlear Implants; Tissue Engineering Implants; Biomaterial Scaffolds
• Companies Mentioned: Medtronic PLC; Stryker Corporation; Zimmer Biomet Holdings Inc.; Dentsply Sirona Inc.; Johnson & Johnson
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain
• Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Bio-Implants Market Characteristics

3. Bio-Implants Market Trends And Strategies

4. Bio-Implants Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics And Covid And Recovery On The Market

5. Global Bio-Implants Growth Analysis And Strategic Analysis Framework

• 5.1. Global Bio-Implants PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 5.2. Analysis Of End Use Industries
• 5.3. Global Bio-Implants Market Growth Rate Analysis
• 5.4. Global Bio-Implants Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
• 5.5. Global Bio-Implants Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
• 5.6. Global Bio-Implants Total Addressable Market (TAM)

6. Bio-Implants Market Segmentation

• 6.1. Global Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cardiovascular Implants
• Dental Implants
• Spinal Bio-Implants
• Orthopaedic Implants
• Ophthalmic Implants
• Other Types
• 6.2. Global Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Metallic
• Ceramic
• Polymer
• Biological
• 6.3. Global Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Allograft
• Autograft
• Xenograft
• Synthetic
• 6.4. Global Bio-Implants Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Ambulatory Surgical Centers
• Clinics
• Hospital
• Other End-Users
• 6.5. Global Bio-Implants Market, Sub-Segmentation Of Cardiovascular Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Stents
• Heart Valves
• Pacemakers
• 6.6. Global Bio-Implants Market, Sub-Segmentation Of Dental Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Endosteal Implants
• Subperiosteal Implants
• Zygomatic Implants
• 6.7. Global Bio-Implants Market, Sub-Segmentation Of Spinal Bio-Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Spinal Fusion Devices
• Intervertebral Discs
• Spinal Rods And Plates
• 6.8. Global Bio-Implants Market, Sub-Segmentation Of Orthopedic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Joint Replacement Implants
• Fracture Fixation Devices
• Bone Plates And Screws
• 6.9. Global Bio-Implants Market, Sub-Segmentation Of Ophthalmic Implants, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Intraocular Lenses (IOLs)
• Retinal Implants
• Corneal Implants
• 6.10. Global Bio-Implants Market, Sub-Segmentation Of Other Types, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• Cochlear Implants
• Tissue Engineering Implants
• Biomaterial Scaffolds

7. Bio-Implants Market Regional And Country Analysis

• 7.1. Global Bio-Implants Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 7.2. Global Bio-Implants Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Bio-Implants Market

• 8.1. Asia-Pacific Bio-Implants Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 8.2. Asia-Pacific Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.3. Asia-Pacific Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 8.4. Asia-Pacific Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Bio-Implants Market

• 9.1. China Bio-Implants Market Overview
• 9.2. China Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.3. China Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
• 9.4. China Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Bio-Implants Market

• 10.1. India Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.2. India Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 10.3. India Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Bio-Implants Market

• 11.1. Japan Bio-Implants Market Overview
• 11.2. Japan Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.3. Japan Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 11.4. Japan Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Bio-Implants Market

• 12.1. Australia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.2. Australia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 12.3. Australia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Bio-Implants Market

• 13.1. Indonesia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.2. Indonesia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 13.3. Indonesia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Bio-Implants Market

• 14.1. South Korea Bio-Implants Market Overview
• 14.2. South Korea Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.3. South Korea Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 14.4. South Korea Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Bio-Implants Market

• 15.1. Western Europe Bio-Implants Market Overview
• 15.2. Western Europe Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.3. Western Europe Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 15.4. Western Europe Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Bio-Implants Market

• 16.1. UK Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.2. UK Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 16.3. UK Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Bio-Implants Market

• 17.1. Germany Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.2. Germany Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 17.3. Germany Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Bio-Implants Market

• 18.1. France Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.2. France Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 18.3. France Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Bio-Implants Market

• 19.1. Italy Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.2. Italy Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 19.3. Italy Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Bio-Implants Market

• 20.1. Spain Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.2. Spain Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 20.3. Spain Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Bio-Implants Market

• 21.1. Eastern Europe Bio-Implants Market Overview
• 21.2. Eastern Europe Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.3. Eastern Europe Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 21.4. Eastern Europe Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Bio-Implants Market

• 22.1. Russia Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.2. Russia Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 22.3. Russia Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Bio-Implants Market

• 23.1. North America Bio-Implants Market Overview
• 23.2. North America Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.3. North America Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 23.4. North America Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Bio-Implants Market

• 24.1. USA Bio-Implants Market Overview
• 24.2. USA Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.3. USA Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 24.4. USA Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Bio-Implants Market

• 25.1. Canada Bio-Implants Market Overview
• 25.2. Canada Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.3. Canada Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 25.4. Canada Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Bio-Implants Market

• 26.1. South America Bio-Implants Market Overview
• 26.2. South America Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.3. South America Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 26.4. South America Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Bio-Implants Market

• 27.1. Brazil Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.2. Brazil Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 27.3. Brazil Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Bio-Implants Market

• 28.1. Middle East Bio-Implants Market Overview
• 28.2. Middle East Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.3. Middle East Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 28.4. Middle East Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Bio-Implants Market

• 29.1. Africa Bio-Implants Market Overview
• 29.2. Africa Bio-Implants Market, Segmentation By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.3. Africa Bio-Implants Market, Segmentation By Material, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
• 29.4. Africa Bio-Implants Market, Segmentation By Origin, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Bio-Implants Market Competitive Landscape And Company Profiles

• 30.1. Bio-Implants Market Competitive Landscape
• 30.2. Bio-Implants Market Company Profiles
  • 30.2.1. Medtronic PLC Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.2. Stryker Corporation Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.3. Zimmer Biomet Holdings Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.4. Dentsply Sirona Inc. Overview, Products and Services, Strategy and Financial Analysis
  • 30.2.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

31. Bio-Implants Market Other Major And Innovative Companies

• 31.1. Arthrex Inc.
• 31.2. Boston Scientific Corporation
• 31.3. Smith & Nephew PLC
• 31.4. B. Braun Melsungen AG
• 31.5. Victrex PLC
• 31.6. Straumann Holding AG
• 31.7. Danaher Corporation
• 31.8. Cardinal Health Inc.
• 31.9. Organogenesis Holdings Inc.
• 31.10. Exactech Inc.
• 31.11. Osprey Medical Inc.
• 31.12. Edwards Lifesciences Corporation
• 31.13. Biotronik SE & Co. KG
• 31.14. aap Implantate AG
• 31.15. Abbott Laboratories

32. Global Bio-Implants Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Bio-Implants Market

34. Recent Developments In The Bio-Implants Market

35. Bio-Implants Market High Potential Countries, Segments and Strategies

• 35.1 Bio-Implants Market In 2029 - Countries Offering Most New Opportunities
• 35.2 Bio-Implants Market In 2029 - Segments Offering Most New Opportunities
• 35.3 Bio-Implants Market In 2029 - Growth Strategies
  • 35.3.1 Market Trend Based Strategies
  • 35.3.2 Competitor Strategies

36. Appendix

• 36.1. Abbreviations
• 36.2. Currencies
• 36.3. Historic And Forecast Inflation Rates
• 36.4. Research Inquiries
• 36.5. The Business Research Company
• 36.6. Copyright And Disclaimer